Blog
Tokens.com Provides Crypto Inventory Update
Tokens.com Corp. (Cboe Canada: COIN | Frankfurt Stock Exchange: 76M | OTCQB: SMURF) (“Tokens.com” or the “Company”), a technology holding company that owns an inventory of cryptocurrencies, is
Scott Ferguson Steps Down From US Foods Board of Directors, Noting Confidence in Company Leadership and Strategy
US Foods Holding Corp. (NYSE: USFD), one of America’s largest foodservice distributors, today announced that Scott Ferguson, Founder and Managing Partner, Sachem Head Capital Management LP has
Dole plc Reports Fourth Quarter and Full Year 2023 Financial Results
Dole plc (NYSE: DOLE) ("Dole" or the "Group" or the "Company") today released its financial results for the three months and year ended December 31, 2023.
Highlights for the year ended December
New Wave of Startups Scale Innovation to Solve Global Water Challenges
A new group of startups is tackling the world’s growing water problems with novel technologies and new approaches to address water shortages, emerging contaminants like PFAS and other “forever
Border To Coast Pensions Partnership Limited Reappoints Northern Trust as its Asset Servicing Provider
Northern Trust (Nasdaq: NTRS) today announced it has been re-appointed by Border To Coast Pensions Partnership Limited (Border To Coast) to provide a range of asset servicing solutions spanning
Syngenta Group expands collaborations for more innovative scientific and technological solutions in agriculture
Syngenta Group, one of the world’s leading global agriculture technology companies, today announced important collaborations following the launch of its innovation accelerator platform Shoots by
CRH Continues Share Buyback Program
CRH plc, the leading provider of building materials solutions, is pleased to announce that it has completed the latest phase of its share buyback program, returning a further $0.3 billion of cash
CRH 2023 Full Year Results
CRH plc (NYSE:CRH) (LSE:CRH):
Key Highlights
Summary Financials (U.S. GAAP)
2023
Change
Total revenues
$34.9bn
+7%
Income from
Fluidra Results in Line With Guidance, With Sales of €2,051 and EBITDA of €445 Million
Fluidra, the global leader in equipment and connected solutions in the pool and wellness sector, achieved sales of €2,051 million in 2023, down 14% compared to the prior year period. This was
Elliptic Labs Shipping on vivo V30 Pro Smartphone
Elliptic Labs (OSE: ELABS), a global AI software company and the world leader in AI Virtual Smart Sensors™ currently deployed in over 500 million devices, has launched its AI Virtual Proximity
Sensorion Announces its Participation in the Leerink Partners Global Biopharma Conference
Regulatory News:
Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within
SES Full Year 2023 Results
SES S.A. announces financial results for the twelve months ended 31 December 2023.
-
Revenue of €2,030 million above Full Year 2023 financial outlook -
Networks (+6.1% YOY(1)) driving group
Clarins Teams Up with Dassault Systèmes to Achieve New Levels of Efficiency at Its Two French Production Sites
Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced that Clarins Group, the family-owned global cosmetics group, has selected Dassault Systèmes’ solutions to transform its
Sitio Royalties Reports Fourth Quarter and Full Year 2023 Operational and Financial Results, Recent Developments, and Provides Full Year 2024 Guidance
Sitio Royalties Corp. (NYSE: STR) (“Sitio”, “STR” or the “Company”) today announced operational and financial results for the quarter and year ended December 31, 2023. Unless the context clearly
AB InBev Reports Full Year and Fourth Quarter 2023 Results
AB InBev (Brussel:ABI) (BMV:ANB) (JSE:ANH) (NYSE:BUD):
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240228688664/en/
Figure 14
ISG Announces 2024 ISG Paragon Awards™ ANZ Winners
Information Services Group (ISG) (Nasdaq: III), a leading global technology research and advisory firm, has announced the winners of the 2024 ISG Paragon Awards™ ANZ, which celebrate the ongoing
Cactus Announces Fourth Quarter and Full Year 2023 Results
Cactus, Inc. (NYSE: WHD) (“Cactus” or the “Company”) today announced financial and operating results for the fourth quarter and full year of 2023.
Fourth Quarter Highlights
-
Revenue of $274.9
SunOpta Announces Fourth Quarter and Fiscal 2023 Financial Results
SunOpta Inc. (“SunOpta” or the “Company”) (Nasdaq:STKL) (TSX:SOY), a U.S.-based global pioneer fueling the future of sustainable, plant-based foods and beverages, today announced financial results
Granite Announces Fourth Quarter and Year End Results for 2023 and the Appointment of a New Trustee
Granite Real Estate Investment Trust and Granite REIT Inc. (TSX: GRT.UN; NYSE: GRP.U) (“Granite” or the “Trust”) announced today its combined results for the three month period and year ended
Dan Simkowitz to Speak at the Annual Morgan Stanley European Financials Conference
Dan Simkowitz, Co-President of Morgan Stanley, will speak at the Annual Morgan Stanley European Financials Conference which will be held in London, UK on Wednesday, March 13, 2024 at 11:00 a.m. GMT
Establishment Labs Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Guidance
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today
Acadia Healthcare to Participate in Raymond James 45th Annual Institutional Investors Conference
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will present at the Raymond James 45th Annual Institutional Investors Conference, which is being held March 3 - 6
Personalis Reports Fourth Quarter and Full Year 2023 Financial Results
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today reported financial results for the fourth quarter and full year ended December 31, 2023, and provided
Xencor to Present at Upcoming Investor Conferences
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases, today announced that company



